Biotech Firm Moderna Hypes “Promising” Coronavirus Vaccine Trials as Executives Dump Millions in Stock
Moderna’s stock rose spectacularly on news that early trial results of their coronavirus vaccine looked promising. But upon further scrutiny of their data, it looks like the firm’s executives were…